Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
883.20 | 1.18% | 22.16% | 3,934,511.59 | 1.06% | 18.5% |
|
NYSE:MRK
Merck
|
130.06 | -9.24% | 4.07% | 329,416.79 | 2.37% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
123.70 | 16.38% | 38.62% | 191,764.07 | 2% | 15.98% |
|
NasdaqGS:AMGN
Amgen
|
310.15 | -11.6% | -2.74% | 166,375.22 | 2.9% | 5.31% |
|
NYSE:PFE
Pfizer
|
28.01 | 10.86% | 41.77% | 158,721.27 | 6% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
94.33 | 12.8% | 30.73% | 117,784.75 | 3.99% | 8.19% |
|
ASX:CSL
CSL
|
279.18 | 22.87% | 43.8% | 134,914.5 | 1.28% | 7.18% |
|
NasdaqGS:BIIB
Biogen
|
221.50 | -11.75% | 3.9% | 32,249.71 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
28.96 | 65.34% | 81.47% | 28,446.09 | 0.38% | 1.47% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
81.03 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NasdaqGS:RIGL
Rigel Pharmaceuticals
|
0.98 | 0% | 0% | 208.7 | 0% | 0% |
